Preoperative Positron Emission Tomography with Fluorine‐18‐Fluorodeoxyglucose is Predictive of Prognosis in Patients with Hepatocellular Carcinoma after Resection

This publication has 25 references indexed in Scilit:

• [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
  2004
• 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma
  The Esophagus, 2004
• Dual-phase 18F-fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2004
• Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey
  Cancer, 2004
• Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
  2004
• Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors
  Zeitschrift für Krebsforschung und Klinische Onkologie, 2004
• Whole-body FDG-PET imaging in the management of patients with cancer
  Seminars in Nuclear Medicine, 2002
• Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma
  British Journal of Surgery, 1999
• Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting
  The American Journal of Cardiology, 1989
• Prediction of survival in glioma patients by means of positron emission tomography
  Journal of Neurosurgery, 1985